Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

Berry Oncology launches HIFI Pan-Cancer Screening, a multi-cancer early screening product for detecting six high-risk cancers at one time

BEIJING, June 23, 2022 /PRNewswire/ -- On June 23, Berry Oncology, a global leading company specialized in genomic testing and early cancer screening, announced the launch of its innovative one-time precision product HIFI Pan-Cancer Screening, which is an early multi-cancer screening product ...

2022-06-23 22:39 2552

Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies

* Expansion doubles production of the most highly potent active pharmaceutical ingredients (HPAPIs) * Merck now one of industry's largest manufacturers of these components globally * Builds on company's 30 years' CDMO experience with multi-step, complex, and highly potent compounds DARMSTAD...

2022-06-23 21:00 2459

Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies

I-Mab Receives Top Rankings in Five Categories by Institutional Investor

GAITHERSBURG, Md. and SHANGHAI, June 23, 2022 /PRNewswire/ -- I-Mab ("I-Mab" or the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that it was ranked among the top companies i...

2022-06-23 20:00 1364

Fosun International's FTSE Russell ESG Rating Upgraded and Becomes First-time Constituent of FTSE4Good Index Series

HONG KONG, June 23, 2022 /PRNewswire/ -- The world's leading index company, FTSE Russell, recently announced the latest ESG (Environmental, Social and Governance) rating results of Fosun International Limited (HKEX stock code: 00656) ("Fosun International"). Fosun International's FTSE Russell ESG...

2022-06-23 18:56 3306

Fosun International's FTSE Russell ESG Rating Upgraded and Becomes First-time Constituent of FTSE4Good Index Series

SCG Cell Therapy Presents Clinical Proof-of-Concept Data at International Liver Congress (ILC) 2022 Annual Meeting

* Clinical trial interim results of SCG101 shows tumour control with lesion shrinkage observed in two out of three patients with advanced HBV-related HCC * Results show rapid and significant serum HBsAg reduction indicates signal of antiviral activity * Data presented support the advancement...

2022-06-23 17:11 1739

How Can Digitalization of Medical Devices Boost Productivity in Med-tech

The digital transformation of medical devices encourages medtech players to deliver significant value for providers and patients, says Frost & Sullivan. SAN ANTONIO, June 23, 2022 /PRNewswire/ -- The global medical devices industry is undergoing a major transformation in business models, technolo...

2022-06-23 15:12 3079

How Can Digitalization of Medical Devices Boost Productivity in Med-tech

Ocumension OT-401 (Product name: YUTIO), a treatment for chronic non-infectious uveitis officially approved for marketing by the National Medical Products Administration

BEIJING, June 23, 2022 /PRNewswire/ -- Ocumension Therapeutics （1477.HK）announced that the New Drug Application (NDA) for the core product in its pipeline, OT-401 (Sterile non-bioerodible intravitreal implant, Product name: YUTIO), was officially approved by the National Pharmaceutical Administ...

2022-06-23 12:19 2161

A Painless, Micro Injection that One Can Do Oneself with the Latest Chula's Innovation "Detachable and Dissolvable Microneedles"

BANGKOK, June 23, 2022 /PRNewswire/ -- A startup under the umbrella of CU Innovation Hub in collaboration with the Chula Faculty of Science has developed an innovative"Detachable and Dissolvable Microneedle" that makes any injections easy and painless for everyone, while also significantly reduci...

2022-06-23 10:00 2256

A Painless, Micro Injection that One Can Do Oneself with the Latest Chula's Innovation

GSK Malaysia Launches Their #GiveBack Recycling Campaign for Safe Disposal of Old Inhalers

Reducing greenhouse gas emissions and material waste from harming the environment PETALING JAYA, Malaysia, June 23, 2022 /PRNewswire/ -- GSK Malaysia is committed to its long-term ambition of delivering net zero emissions across all operations by 2030. By striving to reduce its environmental imp...

2022-06-23 09:22 3492

GSK Malaysia Launches Their #GiveBack Recycling Campaign for Safe Disposal of Old Inhalers

China Pharma Announces Receipt of Noncompliance Notice from NYSE American

HAIKOU, China, June 22, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that onJune 15, 2022, the Company received a letter from NYSE American LLC ("NYSE American" or the "Exchange"...

2022-06-23 05:00 2453

First American Patient Treated with VenusP-Valve™ Under Compassionate Use

HANGZHOU, China, June 22, 2022 /PRNewswire/ -- VenusP-Valve™, an in-house developed novel medical device of Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as "Venus Medtech"), recently completed its first compassionate use atUniversity of Virginia Advanced Cardiac Valve Center in...

2022-06-22 18:02 2026

First American Patient Treated with VenusP-Valve™ Under Compassionate Use

2022 Tang Prize Laureates--Six Voices that Provide Stability to the World

TAIPEI, June 22, 2022 /PRNewswire/ -- Since the outbreak of COVID-19, more than 530 million inflections have been reported globally. With the virus still raging in many countries, the world is suffering from supply chain disruptions and decade-high inflation, which has been exacerbated by the ris...

2022-06-22 10:30 775

2022 Tang Prize Laureates--Six Voices that Provide Stability to the World

Sirnaomics to Present the Latest Developments of Dual-Targeted RNAi Therapeutics based on its Proprietary GalAhead™ Program at the 4th Annual RNA Therapeutic: From Concept to Clinic Symposium

GAITHERSBURG, Md. and SUZHOU, China, June 22, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced that the Company's Chief Technology Officer,Dmitry Samarsky, Ph...

2022-06-22 00:29 2512

JNCCN: Mismatch in Breast Cancer Trial Results and Real-World Outcomes Based on Treatment Discontinuation

New population study on adjuvant hormone therapy for breast cancer finds correlation between hot flashes and poorer outcomes—in contrast to clinical trial results; likely due to patients with side-effects ending treatment early. PLYMOUTH MEETING, Pa., June 21, 2022 /PRNewswire/ -- New research in...

2022-06-21 20:39 1412

Zeus Invests in Global Expansion Program to Increase Catheter Manufacturing Capacity

ORANGEBURG, S.C., June 21, 2022 /PRNewswire/ -- Zeus, the global leader in advanced polymer solutions, today announced a multi-million dollar investment to expand its catheter manufacturing capacity worldwide. The first phase of the expansion program is already underway at the company'sSan Jose l...

2022-06-21 20:00 1381

Apowiser Raises $1.5M In Seed Funding from Longliv Ventures, a Member of CK Hutchison Holdings, to Expand the Global Reach of its Novel Digital Platform that Empowers Consumers to make Informed Choices when Selecting Over-the-Counter Medications

RA'ANANA, Israel, June 21, 2022 /PRNewswire/ -- Apowiser , an early-stage Israeli start-up that has developed PharmAssist , a chatbot-based system to support customers in the online purchase of Over-the-Counter (OTC) drugs a...

2022-06-21 19:00 2119

Fosun's Innovative Achievements Continue to Make Breakthroughs

Thanks to its Robust Global Ecosystem, Fosun's Various Business Segments Continue to Achieve Growth HONG KONG, June 21, 2022 /PRNewswire/ -- With the resumption of work, production, and business operations inShanghai, the 4th 515 Fosun Family Day, which has been ongoing for more than a month, us...

2022-06-21 17:04 2036

Fosun's Innovative Achievements Continue to Make Breakthroughs

Prof. Cho, head of the lung cancer center at Yonsei Cancer Hospital, "J INTS BIO's new oral administration 4th generation EGFR TKI 'JIN-A02' expected to be a game changer"

SEOUL, South Korea, June 21, 2022 /PRNewswire/ -- Prof. Cho Byoung-chul at Yonsei University College of Medicine (Director, Lung Cancer Center, Yonsei Cancer Hospital) is one of the most influential researchers in the lung cancer field and is involved in the development of innovative new drugs gl...

2022-06-21 17:00 1343

Prof. Cho, head of the lung cancer center at Yonsei Cancer Hospital,

Nippon Express Launches New Transport Service Using Environment-friendly Isothermal Packaging

TOKYO, June 21, 2022 /PRNewswire/ -- -First Japanese Logistics Company to Collaborate with EMBALL'ISO, Experienced in Vaccine Transport- Nippon Express Co., Ltd., a group company of Nippon Express Holdings, Inc., has become the first Japanese logistics company to collaborate with EMBALL'ISO, a...

2022-06-21 14:00 895

Nippon Express Launches New Transport Service Using Environment-friendly Isothermal Packaging

-First Japanese Logistics Company to Collaborate with EMBALL'ISO, Experienced in Vaccine Transport- TOKYO, June 21, 2022 /PRNewswire/ -- Nippon Express Co., Ltd., a group company of Nippon Express Holdings, Inc., has become the first Japanese logistics company to collaborate with EMBALL'ISO, a F...

2022-06-21 14:00 1513

1 ... 231 232 233234235 236 237 ... 576